These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 20055588)

  • 1. Can we treat our way out of HIV?
    Johnston R; Collins C
    AIDS Res Hum Retroviruses; 2010 Jan; 26(1):1-4. PubMed ID: 20055588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A way forward: the National HIV/AIDS Strategy and reducing HIV incidence in the United States.
    Millett GA; Crowley JS; Koh H; Valdiserri RO; Frieden T; Dieffenbach CW; Fenton KA; Benjamin R; Whitescarver J; Mermin J; Parham-Hopson D; Fauci AS
    J Acquir Immune Defic Syndr; 2010 Dec; 55 Suppl 2():S144-7. PubMed ID: 21406986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of year 2020 goals for the National HIV/AIDS Strategy for the United States.
    Holtgrave DR
    AIDS Behav; 2014 Apr; 18(4):638-43. PubMed ID: 23934340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A SWOT Analysis of the Updated National HIV/AIDS Strategy for the U.S., 2015-2020.
    Holtgrave DR; Greenwald R
    AIDS Behav; 2016 Jan; 20(1):1-6. PubMed ID: 26370101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of the US National HIV/AIDS Strategy targets for improved HIV care engagement: a modelling study.
    Shah M; Perry A; Risher K; Kapoor S; Grey J; Sharma A; Rosenberg ES; Del Rio C; Sullivan P; Dowdy DW
    Lancet HIV; 2016 Mar; 3(3):e140-6. PubMed ID: 26939737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Costs, consequences and feasibility of strategies for achieving the goals of the National HIV/AIDS strategy in the United States: a closing window for success?
    Holtgrave DR; Hall HI; Wehrmeyer L; Maulsby C
    AIDS Behav; 2012 Aug; 16(6):1365-72. PubMed ID: 22610372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. U.S. HIV Incidence and Transmission Goals, 2020 and 2025.
    Bonacci RA; Holtgrave DR
    Am J Prev Med; 2017 Sep; 53(3):275-281. PubMed ID: 28522237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Separate goals, converging priorities: on the ethics of treatment as prevention.
    Ostmann F; Saenz C
    Dev World Bioeth; 2013 Aug; 13(2):57-62. PubMed ID: 23800304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reaping the prevention benefits of highly active antiretroviral treatment: policy implications of HIV Prevention Trials Network 052.
    Forsyth AD; Valdiserri RO
    Curr Opin HIV AIDS; 2012 Mar; 7(2):111-6. PubMed ID: 22227586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The United States government's response to HIV/AIDS today: 'test and treat' as prevention.
    Berkelman R
    J Public Health Policy; 2012 Aug; 33(3):337-43. PubMed ID: 22895503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating the Impact of the US National HIV/AIDS Strategy, 2010-2015.
    Bonacci RA; Holtgrave DR
    AIDS Behav; 2016 Jul; 20(7):1383-9. PubMed ID: 27129453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preventing HIV transmission through antiretroviral treatment-mediated virologic suppression: aspects of an emerging scientific agenda.
    Dieffenbach CW
    Curr Opin HIV AIDS; 2012 Mar; 7(2):106-10. PubMed ID: 22227584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Battling AIDS in America: an evaluation of the National HIV/AIDS Strategy.
    Yehia B; Frank I
    Am J Public Health; 2011 Sep; 101(9):e4-8. PubMed ID: 21778507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.
    Broz D; Wejnert C; Pham HT; DiNenno E; Heffelfinger JD; Cribbin M; Krishna N; Teshale EH; Paz-Bailey G;
    MMWR Surveill Summ; 2014 Jul; 63(6):1-51. PubMed ID: 24990587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shifting Resources and Focus to Meet the Goals of the National HIV/AIDS Strategy: The Enhanced Comprehensive HIV Prevention Planning Project, 2010-2013.
    Flores SA; Purcell DW; Fisher HH; Belcher L; Carey JW; Courtenay-Quirk C; Dunbar E; Eke AN; Galindo CA; Glassman M; Margolis AD; Neumann MS; Prather C; Stratford D; Taylor RD; Mermin J;
    Public Health Rep; 2016; 131(1):52-8. PubMed ID: 26843670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and behavioral characteristics of adults receiving medical care for HIV infection --- Medical Monitoring Project, United States, 2007.
    Blair JM; McNaghten AD; Frazier EL; Skarbinski J; Huang P; Heffelfinger JD
    MMWR Surveill Summ; 2011 Sep; 60(11):1-20. PubMed ID: 21881551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial.
    ; de Vincenzi I
    Lancet Infect Dis; 2011 Mar; 11(3):171-80. PubMed ID: 21237718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV infection and zidovudine use in childbearing women.
    Sia J; Paul S; Martin RM; Cross H
    Pediatrics; 2004 Dec; 114(6):e707-12. PubMed ID: 15545619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment as prevention among injecting drug users; extrapolating from the Amsterdam cohort study.
    de Vos AS; Prins M; Coutinho RA; van der Helm JJ; Kretzschmar ME
    AIDS; 2014 Mar; 28(6):911-8. PubMed ID: 24401639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paediatric HIV infection.
    Friesen H
    P N G Med J; 1996 Sep; 39(3):183-9. PubMed ID: 9795560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.